Cell Separation Technologies Market Outlook 2031

1. Cell Separation Technologies Market Outlook 2031 The globalcell separation technologies market was valued at US$ 6.6 Bn in 2021 The global market is projected to grow at a CAGR of 11.9% from 2022 to 2031 The globalcell separation technologies market is anticipated to surpass US$ 20.3 Bn by the end of 2031    Report technologies.html Overview: https://www.transparencymarketresearch.com/cell-separation- Cell Separation Technologies Market Introduction Cell separation is the process of removing specific cells from heterogeneous or homogenous subpopulations, and has superior biomedical and clinical applications. Cell separation techniques are used to isolate cells with high purity, which aids in the identification and diagnosis of cells. Cell separation is a powerful technology that assists biological research. According to the latest report published by Transparency Market Research, the revenue of the global cell separation technologies market is expected to grow at a moderate pace during the forecast period. This can be attributed to technological advancements and surge in investments in research & development such as stem cell research and cancer research. Rise in the geriatric population is another factor boosting the need of cell separation technologies. The geriatric population is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop a treatment for chronic illnesses. Furthermore, rise in awareness about innovative technologies, such as microfluidics, fluorescent activated cell sorting, and magnetic-activated cell sorting is expected to propel the global cell separation technologies market. Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=192 5 Request a sample to get extensive insights into the Cell Separation Technologies Market Increase in Prevalence of Chronic Diseases Driving Global Market

2. Rise in chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer is increasing due to sedentary lifestyle, aging of the global population, and rise in alcohol consumption and cigarette smoking. According to Imperial College London, in 2020, chronic diseases are estimated to account for around 41 million deaths each year, constituting seven out of 10 deaths globally. Of these deaths, nearly 17 million are classified as premature, with people dying younger than expected on average. Hence, increase in the burden of chronic diseases is fueling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments toward research to develop effective treatments. Therefore, increase in cellular research activities is propelling the global cell separation technologies market. Surge in Geriatric Population Boosting Demand for Clinical Trials and Research The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more often than the younger population. Moreover, the geriatric population is increasing at a rapid pace compared to the younger population. An increase in population aged 65 years & above is projected to drive the incidence of Alzheimer’s, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need of corrective treatment of these disorders. This is likely to drive the demand for clinical trials and research, which require cell separation products. These factors are projected to propel the global cell separation technologies market. According to the United Nations, the geriatric population aged above 60 is expected to double by 2050 and triple by 2100, an increase from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion by 2100. Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1 925 Request a custom report on Cell Separation Technologies Market Productive Partnerships in Microfluidics to Fueling Cell Separation Technologies Market Growth Technological advancements are prompting companies to innovate in the microfluidics cell separation technology. Strategic partnerships and collaborations are an ongoing trend, which is boosting innovation and development of microfluidics-based products. Governments and stakeholders recognize the potential in the single-cell separation technology and its analysis, which drives them to invest

3. in the development of microfluidics. Companies strive to build a platform by utilizing their expertise and experience to offer enhanced solutions to end-users. Usage in Development of Regenerative Medicine Driving Stem Cell Research Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs rather than treating them. Hence, the stem cell research segment accounted for a prominent share of the global market in 2021. The geriatric population is likely to increase at a rapid pace compared to the adult population by 2030, which is projected to increase the use of stem cell therapy for treatment. Stem cells require a considerably higher number of clinical trials, which is anticipated to drive the demand for cell separation technology globally. Rise in stem cell research is expected to attract government and private funding, which, in turn, is likely to offer significant opportunities in stem cell separation technologies. Rising Implementation of Cell Separation Techniques in Biotechnology & Pharmaceutical Companies The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cell separation techniques to develop drugs and continue contributing to innovation. The growing research in stem cells has prompted companies to own large separate units to boost the same. Hence, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the biotechnology & pharmaceutical companies segment. According to research, 449 public biotech companies operate in the U.S., which is expected to propel the biotechnology & pharmaceutical companies segment. Regional Outlook of Global Cell Separation Technologies Market In terms of region, the global cell separation technologies market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2021, followed by Europe. North America accounted for a key share of the global cell separation technologies market in 2021, owing to the development of advanced cell separation technologies, well-defined regulatory framework, and initiatives by governments in the region to further encourage the research industry. The U.S. is a large investor in stem cell research, which is accelerating the development of regenerative medicines for the treatment of various long-term illnesses. The cell separation technologies market in Asia Pacific is projected to grow at a high CAGR from 2022 to 2031. This can be ascribed to the increase in healthcare expenditure

4. and large patient population, especially in countries such as India and China. Growing medical tourism in the region and technological advancements are anticipated to augment the cell separation technologies market in the region. Analysis of Key Players in Global Cell Separation Technologies Market The global cell separation technologies market is highly competitive in terms of the number of players. Key players operating in the global cell separation technologies market include Akadeum Life Sciences, STEMCELL Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Miltenyi Biotec, 10X Genomics, Thermo Fisher Scientific, Inc., Carl Zeiss AG, Cytiva, PerkinElmer, Inc., and QIAGEN. These players have adopted various strategies such as diversifying their product portfolio by launching new cell separation kits & devices, participating in acquisitions, and establishing a strong distribution network. The companies are growing their geographic presence in order to sustain themselves in the global cell separation technologies market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products. In July 2017, Becton, Dickinson and Company received the U.S. FDA’s clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders. About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End- Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

5. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com